Clinical Trial Update: Growth Hormone Treatment in Infants Aged 1 to 2 Years With Chronic Renal Insufficiency (CRI) and Growth Retardation. [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating growth hormone treatment in infants aged 1 to 2 years with chronic kidney disease or chronic renal insufficiency has completed, spons…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Renal Insufficiency

Drugs mentioned

• Norditropin (somatropin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Chronic Kidney Disease, Chronic Renal Insufficiency | Phase 4 | Status: COMPLETED